SEC Proposes Climate-Related Company Data is Measured, Reported, and Mandated

Key Insights:

  • The SEC proposes an update to financial reporting standards for the energy and transportation industry.
  • Companies need to take inventory of where they are and where they want to go.
  • Collaboration is key – it’s not just one company impacted, it’s the entire supply chain.

In March 2022, the Securities and Exchange Commission (SEC) made a major proposal that would affect the financial reporting standards of the energy and transportation industry. “The SEC has proposed that companies be responsible for measuring and reporting their emissions on a regular basis – similar to their quarterly report or annual report,” explained Lynn Lyon, Director of Business Development, U.S. Gain.

This is a significant step for the SEC and is potentially the most disruptive act in 20 years. It’s a truly transformative, future-forward proposal requiring companies to report “information about climate-related risks that are reasonably likely to have a material impact on their business, results of operations, or financial condition, and certain climate-related financial statement metrics in a note to their audited financial statements” (SEC). The rule would also apply to foreign companies that are publicly traded within the US.

Lyon noted that this is both an exciting and scary time for the industry. “On a personal level, I find it a positive step for us that we are looking towards the future and how what we do financially impacts the environment.” The proposal allows companies to put a plan in place for the future while taking a pragmatic view of what is possible. Some companies are already doing this voluntarily giving them a potential leg up on those who will need to catch up.

Speaking about industry responsibilities, Lyon believes that companies need to take an “inventory of what we currently have, where our emissions are coming from, how do we baseline it because you have to baseline it to find the basis for improvements.” When this is done, it’s time to figure out what companies are willing to do to change.

As climate-related issues continue to make headlines, companies are increasingly under pressure to decrease emissions and reduce environmental footprints. “The proposal is aimed at requiring companies to disclose how they integrate climate risks and opportunities into their governance and corporate strategy along with a significant amount of related qualitative and quantitative information.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More